• Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

  • Jul 22 2024
  • Duración: 35 m
  • Podcast

Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, Dr Virginia Kaklamani moderates a discussion with Dr Aditya Bardia and Dr Sarah Sammons answering audience questions on the latest data on the use of oral SERDs therapy, including how to incorporate this new class of therapy into treatment plans for patients with HR+/HER2- breast cancer.

    Presenters:
    Virginia Kaklamani, MD, DSc
    Professor of Medicine
    Ruth McLean Bowman Bowers Chair in Breast Cancer Research and Treatment
    A.B. Alexander Distinguished Chair in Oncology Leader
    Breast Oncology Program
    UT Health San Antonio
    MD Anderson Cancer Center
    San Antonio, Texas

    Aditya Bardia, MD, MPH, FASCO
    Professor of Medicine
    Geffen School of Medicine at UCLA
    Director, Breast Oncology Program
    Assistant Chief (Translational Research)
    Division of Medical Oncology
    Director of Translational Research Integration
    UCLA Health Jonsson Comprehensive Cancer Center
    Los Angeles, California

    Sarah Sammons, MD
    Assistant Professor of Medicine
    Dana-Farber Cancer Institute
    Harvard Medical School
    Boston, Massachusetts

    Link to full program:
    https://bit.ly/46hLGcM
    Más Menos
activate_WEBCRO358_DT_T2
Educación Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Next-Generation Therapeutics for HR+/HER2- Breast Cancer: Spotlight on SERDs

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles